Article Information
History
- December 13, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Manishkumar S. Patel1,
- Agrima Mian2,
- Akansha Jalota1,
- Peter Bazeley3,
- Sujata Patil3,4,
- Brian T. Hill2 and
- Neetu Gupta1,*
- 1Department of Inflammation and Immunity, Lerner Research Institute
- 2Department of Hematology and Medical Oncology, Taussig Cancer Institute
- 3Department of Quantitative Health Sciences, Lerner Research Institute
- 4Department of Cancer Biostatistics, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
- ↵*Correspondence to
: Neetu Gupta, Ph.D.; 9500 Euclid Avenue, NE40, Cleveland, OH 44195; Email: guptan{at}ccf.org; Phone: (216) 444-7455; Fax: (216) 444-9329
Posted December 13, 2024.
Sex-specific Risk Factors for Survival in B-cell Non-Hodgkin Lymphoma Patients after Anti-CD19 CAR T-Cell Therapy
